Skip to main content

9 Result(s)

within William A. Murphy Remove this filter

and

  1. No Access

    Article

    Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation

    We aimed to study the utility of the FRAX tool in predicting fractures in patient’s receiving a hematopoietic stem cell transplantation (HSCT). Our results indicate that the FRAX tool has modest fracture predi...

    Xerxes Pundole, William A. Murphy, Chidinma C. Ebede… in Archives of Osteoporosis (2018)

  2. No Access

    Article

    A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit

    Somatostatin analogs have been shown to inhibit vascular smooth muscle cell (VSMC) proliferation and attenuate neointimal thickening following experimental balloon catheter injury. In this study, the effects o...

    Natali K. Schiller, Alvin M. Timothy… in Molecular and Cellular Biochemistry (2002)

  3. No Access

    Chapter

    Somatostatin receptor antagonists based on a mixed neuromedin B antagonist/somatostatin agonist

    David H. Coy, Rahul Jain, William A. Murphy… in Peptides Frontiers of Peptide Science (2002)

  4. No Access

    Chapter

    Exploration of the DTrp-NMeLys Motif in the Search for Potent Somatostatin Antagonists

    Somatostatin (SRIF), a tetradecapeptide discovered by Brazeau et al. [1] has been shown to have potent inhibitory effects on various secretory processes in tissues such as pituitary, pancreas or gastrointestinal ...

    W. G. Rajeswaran, William A. Murphy, John E. Taylor… in Peptides: The Wave of the Future (2001)

  5. No Access

    Chapter and Conference Paper

    Pharmacology of GRF and Somatostatin: Positive and Negative Control of GH Release

    The physiological mechanism(s) controlling the release of growth hormone (GH) from the adenohypophysis is unique in having two hormones, growth hormone releasing factor (GRF) (1, 2) and somatostatin (SRIF) (3), t...

    David H. Coy, William A. Murphy, Simon J. Hocart, John Taylor in Growth Hormone II (1994)

  6. No Access

    Article

    Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia

    Cynthia T. McMurtry, Francine W. Schranck, Denise A. Walkenhorst… in Pediatric Nephrology (1993)

  7. Article

    Calcaneal and pelvic fractures: Diagnostic evaluation by three-dimensional computed tomography scans

    A major application of three-dimensional (3D) computed tomography (CT) is in the imaging of the skeleton. 3D CT has a potentially important role in determining the presence, type, and extent of fractures, espe...

    Michael W. Vannier MD, Charles F. Hildebolt, Louis A. Gilula… in Journal of Digital Imaging (1991)

    Download PDF (2861 KB)

  8. No Access

    Chapter

    Somatostatin Agonists and Antagonists - Peptide Control of Growth Hormone Secretion

    Although somatostatin itself has numerous inhibitory activities which individually are of no little therapeutic interest, there are also several types of physiological effects where it might be of even greater...

    David H. Coy, William A. Murphy, Valentine A. Lance, Simon J. Hocart… in Somatostatin (1985)

  9. No Access

    Article

    The effects of salt depletion on blood and tissue ion concentrations in the freshwater mussel,Ligumia subrostrata (Say)

    The extracellular and intracellular fluid volumes of pondwater acclimatedLigumia subrostrata are equal (3.9 ml/g dry tissue). Total blood solute is 47 mOsm and is composed primarily of Na (19.1 mM), Cl (10.6 mM),...

    William A. Murphy, Thomas H. Dietz in Journal of comparative physiology (1976)